1. Home >
  2. M&A >
  3. Consolidation >
  4. United States >
  5. Ohio >
  6. Arsenal Capital Partners Acquires PSG

M&A Deal Summary

Arsenal Capital Partners Acquires PSG

On June 30, 2015, private equity firm Arsenal Capital Partners acquired chemicals company PSG

Acquisition Highlights
  • This is Arsenal Capital Partners’ 11th transaction in the Chemicals sector.
  • This is Arsenal Capital Partners’ 28th transaction in the United States.
  • This is Arsenal Capital Partners’ 3rd transaction in Ohio.
Investment Fate
  • PSG was sold to a consortium of financial buyers in 2019.

M&A Deal Summary
Date 2015-06-30
Target PSG
Sector Chemicals
Buyer(s) Arsenal Capital Partners
Deal Type Consolidation

Target

PSG

Cleveland, Ohio, United States
PSG is a manufacturer of proprietary and custom polymer additives, dispersions, and performance chemicals for the rubber, plastic, and engineered wood industries. PSG offers a variety of customer-centric solutions that improve polymer processing, increase surface protection, and enhance product performance. PSG was founded in 2015 and is based in Cleveland, Ohio.

Search 205,859 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Arsenal Capital Partners

New York, New York, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2000
PE ASSETS 10.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Arsenal Capital Partners is a private equity firm focused on middle-market healthcare, specialty industrial, and financial service companies. Specifically, Arsenal looks to acquire businesses in the areas of specialty chemicals, aerospace/defense, transportation, environmental services, business services, insurance, asset management, financial technology, medical products, healthcare IT, and healthcare contract research/manufacturing. The Firm typically seeks to commit $50 to $300 million per investment in profitable businesses with at least $10 million of EBITDA. Funds are generally used to support buyouts, recapitalizations, growth financings, consolidations, and divestitures. The Firm avoids investing in companies reliant on high levels of technology. Arsenal Capital Partners was formed in 2000 and is headquartered in New York City.

DEAL STATS #
Overall 29 of 57
Sector (Chemicals) 11 of 16
Type (Consolidation) 3 of 8
State (Ohio) 3 of 3
Country (United States) 28 of 50
Year (2015) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-06-19 Royal Adhesives & Sealants

South Bend, Indiana, United States

Royal Adhesives & Sealants LLC is a producer of proprietary, high-performance adhesives and sealants. Royal offers a broad range of specialty formulated products designed to solve complex bonding, laminating and sealing applications across a diverse range of markets including aerospace and defense, construction, specialty packaging, automotive and industrial.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-01-05 BioIVT

Hicksville, New York, United States

BioIVT is a provider of biological products to life sciences and pharmaceutical companies. BioIVT specializes in control and disease state matrices manufactured from human and animal blood, plasma, serum, tissues, and other fluids which are used in drug discovery, compound development, clinical and research diagnostics. BioIVT was founded in 1981 and is based in Hicksville, New York.

Buy -
Mergr

Product

Company

Legal